Indianapolis, Fort Wayne, Bloomington, Evansville. IV ketamine, Spravato, and telehealth options compared.
Estimate cost in IndianaKetamine treatment in Indiana is concentrated in Indianapolis (Marion County) with smaller clinic clusters in Fort Wayne, Bloomington, Evansville, and South Bend. Prescribing is regulated by the Indiana Medical Licensing Board with controlled-substance oversight from the Indiana Professional Licensing Agency and the DEA. This site is an independent directory built for patients, not clinics.
Clinics listed by Indiana metro with verifiable Indiana Medical Licensing Board status.
Indiana cash-pay is typically below coastal averages; Spravato coverage is broad with prior auth.
Controlled-substance prescribing in Indiana feeds the INSPECT PDMP; relevant for ketamine prescribing.
Where Indiana sits within the DEA's evolving telehealth-for-controlled-substances rules.
Per-session and total course estimates for IV, Spravato, IM, and sublingual.
Information, not advice. Cost ranges are typical published per-session ranges and may not reflect a specific clinic. Consult a licensed provider for an individualized quote.
Indiana Medical Licensing Board, INSPECT PDMP, DEA scheduling.
Information only. Regulations change. Confirm current rules with the state medical board and DEA before booking treatment.
Commercial, Medicare, Indiana HIP/Medicaid, VA.
Information only. Confirm benefits with your plan and the treating clinic before scheduling.
Indianapolis has the largest concentration of ketamine providers, including academic-affiliated psychiatry programs and standalone infusion clinics. Fort Wayne, Bloomington, Evansville, and South Bend each host a small number of clinics. Patients in Lafayette, Terre Haute, and Muncie often travel to Indianapolis.
The Indiana Medical Licensing Board regulates physician licensure. License verification is available at in.gov/pla. Indiana operates the INSPECT prescription drug monitoring program, which physicians are required to check before prescribing controlled substances, including ketamine.
Indiana permits telemedicine prescribing of controlled substances under state law when the prescriber is Indiana-licensed and conducts an in-person or synchronous video evaluation. At-home ketamine telehealth currently operates under the DEA's extended pandemic-era flexibility; the proposed Special Registration rule could change this.
Indiana's larger psychiatric practices in Indianapolis, Carmel, Fishers, and Fort Wayne are typically Spravato REMS-certified. The state's Healthy Indiana Plan (HIP) and Medicaid managed care plans generally cover Spravato for treatment-resistant depression with prior authorization.
Information, not advice. Always verify with the Indiana Medical Licensing Board before booking.
Setting, dose, sessions, cost, insurance coverage.
| IV ketamine | Spravato (esketamine) | IM ketamine | Sublingual lozenge | |
|---|---|---|---|---|
| FDA status | Off-label (Schedule III anesthetic) | FDA-approved 2019 for TRD; 2020 for MDD with acute suicidality | Off-label | Off-label, compounded |
| Setting | In-clinic, IV pump, monitored | REMS-certified clinic, 2-hr observation | In-clinic injection, monitored | At home (often telehealth-prescribed) |
| Typical dose | 0.5 mg/kg over 40 min | 56 mg or 84 mg nasal spray | 0.5–1.0 mg/kg | 100–400 mg sublingual |
| Induction protocol | 6 sessions over 2–3 weeks | 8 sessions over 4 weeks (2×/week) | 4–6 sessions over 2–3 weeks | Variable; weekly to 3×/week |
| Maintenance | Boosters every 2–6 weeks | Weekly then biweekly per label | Boosters every 3–6 weeks | Variable, prescriber-directed |
| Insurance coverage | Rare; usually cash-pay | Most commercial, Medicare Part B, most Medicaid (PA required) | Rare; usually cash-pay | Rare; usually cash-pay |
| Typical cost / session | $350–$950 cash | $0–$200 with insurance; $600–$1,200 cash | $200–$575 cash | $150–$425 cash (plus Rx) |
| Driving | No driving for 24 hr | No driving for 24 hr (REMS rule) | No driving for 24 hr | No driving for 24 hr after dose |
| Onset of response | Within hours to days | Within hours to days | Within hours to days | Slower; days to weeks |
Information only — not a treatment recommendation. Best modality depends on diagnosis, insurance, and clinician assessment. The FDA has approved only Spravato (esketamine) for psychiatric use; IV, IM, and lozenge ketamine are prescribed off-label.
Yes. Ketamine is a federal Schedule III controlled substance and Indiana-licensed physicians may prescribe and administer it. The Indiana Medical Licensing Board oversees prescribers and INSPECT (Indiana's PDMP) tracks dispensing.
Indiana's Healthy Indiana Plan and Medicaid managed care plans generally cover Spravato for treatment-resistant depression with prior authorization and documentation of failed antidepressant trials. Check current PDL status with your plan.
Currently yes, under DEA telehealth flexibility for controlled substances and Indiana telemedicine law. Provider must hold Indiana license and conduct a synchronous video evaluation. Watch for the pending DEA Special Registration rule.
IV ketamine in Indiana typically runs $375–$700 cash per session, generally below coastal pricing. Spravato copays range from near-zero with commercial insurance to $600–$1,200 cash. See the cost estimator above.
INSPECT is Indiana's prescription drug monitoring program. Indiana prescribers are required to query INSPECT before prescribing Schedule II–IV controlled substances, which includes ketamine. This is part of normal clinical workflow, not a barrier to treatment.
Yes — Fort Wayne and South Bend host a small number of clinics, and some Chicago-area providers serve patients from northwest Indiana. Patients in rural northern counties often travel to Indianapolis or Fort Wayne.
IV ketamine is off-label and almost always cash-pay; Spravato is FDA-approved esketamine nasal spray administered at REMS-certified clinics and typically covered by insurance. Use the comparison table above.
Tools and information for Hoosiers exploring ketamine treatment. Verify any clinic's Indiana Medical Licensing Board status before booking.
A comprehensive look at ketamine therapy in Indiana in 2026: how it works, state licensing oversight, insurance options, and how to find a provider.
A practical checklist of questions Indiana patients should ask before choosing a ketamine clinic, from credentials to integration support.
What Indiana's 2026 telehealth framework means for ketamine patients: what can be done remotely, what can't, and how IHCP covers it.